GENB
GENERATE BIOMEDI
Health Care·Biotechnology·UNITED STATES
$16.39
MCap $2.1B
as of 2026-09-04
Total
C2w
Fund
E10w
Quant
A2w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
+0.07
Sentiment 36.7%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$16.39
Adaptive Mean
$16.30
+0.09 vs mean
Adaptive σ
0.62
MIDOS BB
$15.07 – $17.53
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
-0.36
ROE
—
Z —
Rev Gr
-37.7%
Z —
EPS Gr
—
Z -0.36
OPM Gr
—
Z —
FCF Yld
—
Z —
EPS Surp
-0.1%
Z —
EPS 3mo Δ
—
Z —
Fwd P/E
-7.19
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
8.35
Q6M
5.62
Q12M
4.18
MA 30/100
1.061
Bullish (MA30 > MA100)
α (Jensen)
1.0904
β (12M)
1.31
σ (12M)
0.893
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
13%
Q Percentile
74%
Divergence
-61.1
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
24.1
RS Pctl
84%
RS Decile
D9
Persistence
2w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.